Share: Facebook Twitter LinkedIn
Activity Provided By:

CMEology

New Treatment Strategies for Pulmonary Arterial Hypertension: Advances in PAH Clinical Trial Design

Access Activity

Overview / Abstract:

This is part 2 of a 2-part activity. Outcomes for patients with pulmonary arterial hypertension (PAH) have improved over the last decade, but mortality remains unacceptably high, particularly among patients with more severe disease. Many patients with PAH continue to experience debilitating symptoms despite medical treatment. In this activity, Dr. Ioana Preston focuses on how clinical trial design in PAH is evolving to become more relevant to patients and clinicians through the use of multicomponent improvement endpoints. This activity consists of text that can be read at your own pace interspersed with short videos of Dr. Preston highlighting take-home points.

Expiration

Aug 22, 2023

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Respiratory Therapy CE

Format

Online

Credits / Hours

0.5

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

Ioana Preston, MD

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Merck Sharp & Dohme Corp.

Keywords / Search Terms

CMEology CMEology Pulmonary arterial hypertension PAH Pulmonary hypertension Endothelin receptor antagonist Guanylate cyclase stimulator Prostacyclin analogue Selective prostacyclin receptor agonist BMPR-II signaling CME, CMEology, epocrates, Free CE, Free CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map